Bionxt Solutions Inc (XPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XPHYF | ZTS | TAK | NBIX | UTHR |
| Company | Bionxt Solutions Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.2836 | 166.96 | 13.27 | 142.03 | 261.41 |
| High | 0.2836 | 172.23 | 13.29 | 143.86 | 266.65 |
| Low | 0.2836 | 166.47 | 13.22 | 140.90 | 260.93 |
| Last | 0.2836 | 168.45 | 13.28 | 143.19 | 266.22 |
| Change | -0.1282 | +2.50 | -0.08 | +1.48 | +5.71 |
| % Change | -31.13% | +1.51% | -0.60% | +1.04% | +2.19% |
| Volume | 100 | 3,337,500 | 1,732,000 | 667,200 | 686,500 |
| 20-Day Average Volume | 3,125 | 4,688,575 | 1,615,810 | 800,745 | 578,030 |
| Previous Close | 0.4118 | 165.95 | 13.36 | 141.71 | 260.51 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3724 | 156.71 | 13.26 | 137.13 | 241.75 |
| 20-Day Raw Stochastic | 1.42% | 86.22% | 46.22% | 86.55% | 98.81% |
| 20-Day Relative Strength | 46.16% | 54.21% | 42.13% | 57.81% | 68.76% |
| Weighted Alpha | -62.07 | -9.36 | -19.03 | +48.72 | +28.84 |
| Today's Opinion | 80% Sell | 40% Sell | 88% Sell | 88% Buy | 88% Buy |
| Previous Opinion | 32% Sell | 56% Sell | 88% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 48% Sell | 56% Sell | 88% Sell | 88% Buy | 32% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -27.76% since 12/07/22 | +5.78% since 04/30/24 | +1.53% since 04/30/24 | +4.11% since 04/30/24 | +13.61% since 04/30/24 |
| Low | 0.2799 on 12/12/22 | 158.04 on 05/01/24 | 13.08 on 05/01/24 | 136.01 on 05/01/24 | 236.65 on 05/01/24 |
| High | 0.4984 on 12/13/22 | 172.23 on 05/07/24 | 13.41 on 05/06/24 | 145.22 on 05/01/24 | 266.65 on 05/07/24 |
| 1-Month | |||||
| %Chg | -24.51% since 11/21/22 | +1.56% since 04/05/24 | -2.50% since 04/05/24 | +3.07% since 04/05/24 | +13.98% since 04/05/24 |
| Low | 0.2799 on 12/12/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 230.39 on 04/16/24 |
| High | 0.5400 on 11/28/22 | 172.23 on 05/07/24 | 13.77 on 04/08/24 | 145.22 on 05/01/24 | 266.65 on 05/07/24 |
| 3-Month | |||||
| %Chg | -22.09% since 09/21/22 | -14.53% since 02/07/24 | -6.35% since 02/07/24 | +5.06% since 02/07/24 | +26.31% since 02/07/24 |
| Low | 0.1977 on 09/30/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 129.15 on 03/01/24 | 208.62 on 02/08/24 |
| High | 0.5400 on 11/28/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 266.65 on 05/07/24 |
| 6-Month | |||||
| %Chg | -39.35% since 06/21/22 | +0.77% since 11/07/23 | -3.63% since 11/07/23 | +22.72% since 11/07/23 | +15.53% since 11/07/23 |
| Low | 0.1977 on 09/30/22 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 0.5400 on 11/28/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 266.65 on 05/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 25,867 | 75,722,152 | 42,282,220 | 14,261,270 | 11,557,788 |
| Shares Outstanding, K | 91,210 | 456,295 | 3,164,837 | 100,637 | 44,366 |
| Annual Sales | 230,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -16,470,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 30,000 | 2,190,000,000 | 7,556,070,000 | 515,300,000 | 677,700,000 |
| Last Quarter Net Income | -1,460,000 | 599,000,000 | 718,900,000 | 43,400,000 | 306,600,000 |
| 60-Month Beta | -0.35 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/28/22 | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 11/25/22 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.00 | 6.86 | 38.76 | 12.41 |